We are live on ! Find out more
PIM

Provident Investment Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 9.4%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+9.4%
3 Year Est. Return
+59.52%
5 Year Est. Return
+71.96%
10 Year Est. Return
+378.31%
AUM
$429M
AUM Growth
+$5.68M
Cap. Flow
+$4.33M
Cap. Flow %
1.01%
Top 10 Hldgs %
58.71%
Holding
55
New
2
Increased
13
Reduced
17
Closed
3

Top Sells

Rank Stock Value
1
RMD icon
ResMed
RMD
+$17.3M
2
VAR
Varian Medical Systems, Inc.
VAR
+$304K
3
AAPL icon
Apple
AAPL
+$223K
4
BP icon
BP
BP
+$219K
5
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$217K

Sector Composition

Rank Sector Weight
1 Healthcare 22.42%
2 Financials 21.92%
3 Consumer Discretionary 18.99%
4 Technology 16.54%
5 Industrials 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$164B
$39.9M 9.31%
375,267
-817
-0.2% -$80K
SHPG
2
DELISTED
Shire pic
SHPG
$36.4M 8.48%
140,410
-180
-0.1% -$44.7K
V icon
3
Visa
V
$688B
$29.8M 6.95%
559,392
+2,120
+0.4% +$114K
EBAY icon
4
eBay
EBAY
$49.4B
$24M 5.58%
1,005,022
+9,628
+1% +$214K
ROP icon
5
Roper Technologies
ROP
$39B
$23.2M 5.4%
158,451
-350
-0.2% -$51.5K
TSCO icon
6
Tractor Supply
TSCO
$17.5B
$20.6M 4.8%
1,675,085
+35,250
+2% +$440K
PCP
7
DELISTED
PRECISION CASTPARTS CORP
PCP
$20.1M 4.69%
85,026
+2,630
+3% +$639K
SBNY
8
DELISTED
Signature Bank
SBNY
$19.7M 4.59%
175,677
+7,705
+5% +$907K
PX
9
DELISTED
Praxair Inc
PX
$19.3M 4.49%
149,342
-300
-0.2% -$39.3K
QCOM icon
10
Qualcomm
QCOM
$165B
$18.9M 4.41%
253,097
+4,606
+2% +$352K
ORLY icon
11
O'Reilly Automotive
ORLY
$76.3B
$18.3M 4.26%
1,825,500
-15,750
-0.9% -$161K
KMX icon
12
CarMax
KMX
$8.04B
$17.2M 4%
+369,878
New +$18.9M
CTSH icon
13
Cognizant
CTSH
$25.1B
$16.7M 3.9%
373,598
+14,975
+4% +$705K
AL
14
DELISTED
Air Lease Corp
AL
$16.1M 3.74%
494,336
+7,385
+2% +$269K
CTRX
15
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$16M 3.74%
380,520
+1,775
+0.5% +$80.7K
FDS icon
16
Factset
FDS
$9.89B
$16M 3.73%
131,824
-1,725
-1% -$213K
MYGN icon
17
Myriad Genetics
MYGN
$301M
$14M 3.25%
362,065
+2,050
+0.6% +$76.5K
TROW icon
18
T. Rowe Price
TROW
$24.5B
$13.9M 3.23%
176,669
+3,284
+2% +$264K
IPGP icon
19
IPG Photonics
IPGP
$3.89B
$11.4M 2.67%
166,260
+5,365
+3% +$361K
FFBC icon
20
First Financial Bancorp
FFBC
$3.61B
$6.22M 1.45%
393,069
BEN icon
21
Franklin Resources
BEN
$17.7B
$5.45M 1.27%
99,825
-2,375
-2% -$133K
SPY icon
22
State Street SPDR S&P 500 ETF Trust
SPY
$819B
$4.95M 1.15%
25,101
-1,035
-4% -$205K
PG icon
23
Procter & Gamble
PG
$342B
$2.83M 0.66%
33,782
-150
-0.4% -$12.3K
XOM icon
24
ExxonMobil
XOM
$628B
$1.52M 0.36%
16,193
WAT icon
25
Waters Corp
WAT
$39.3B
$1.46M 0.34%
14,750
-475
-3% -$49K

Similar funds

Provident Investment Management's Q3 2014 Portfolio in Review

As of Q3 2014, Provident Investment Management held 55 positions worth $429M, up 1.3% from $423M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Provident Investment Management's Q3 2014 filing shows 2 new, 13 increased, 17 reduced and 3 closed positions. Its largest new stake was CarMax: 369,878 shares worth $17.2M. The largest sale was ResMed, an estimated $17.3M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Provident Investment Management's largest Q3 2014 buy was CarMax: 369,878 shares worth $17.2M.
  • Provident Investment Management added most to Signature Bank in Q3 2014, an estimated $907K increase.
  • Provident Investment Management's biggest Q3 2014 reduction was ResMed, cutting an estimated $17.3M.
  • Provident Investment Management fully exited Apple in Q3 2014, selling an estimated $223K.
  • Provident Investment Management's ten largest holdings make up 59% of its $429M portfolio in Q3 2014.
  • Provident Investment Management opened 2 new positions and closed 3 in Q3 2014.
  • Provident Investment Management's portfolio value rose 1.3% quarter-over-quarter to $429M.

Based on Provident Investment Management's 13F filing for Q3 2014, filed 12 Nov 2014.